How do I administer the Q-VAX® Vaccine?

If medical history and pre-vaccination tests – both the blood test AND the skin test – are negative, then it’s appropriate to go ahead and administer Q-VAX® Vaccine, provided the patient does not have other contraindications.1,2 

If the blood test or skin test result is ambiguous, refer to the Australian Immunisation Handbook for advice about how to interpret the finding(s) and the recommended action.3

Seqirus does not endorse the use of Q-VAX® other than as described in the Product Information.

Q-VAX® Vaccine is supplied in a prefilled syringe.

After shaking, 0.5 mL of vaccine solution is administered via subcutaneous injection.#2 

The most common reactions after Q-VAX® vaccination in clinical trials are minor local reactions similar to those observed with other bacterial vaccines.1-3

#As with other injectable vaccines, including Q-VAX® Skin Test solution, appropriate medical treatment and supervision should always be available in case of anaphylactic reactions. Adrenaline should always be readily available whenever the injection is given.

Recording screening test results and immunisation status is important

The results of a patient’s Q-VAX® screening tests (blood test, Q-VAX® Skin Test), along with that patient’s current immunisation status, may be documented on a Q fever Pre-Screening and Immunisation Record Card, available upon request using the materials request form in Educational Resources.

The same details should also be submitted to the Australian Q Fever Register (www.qfever.org), provided you have first obtained the patient’s consent to do this. This documentation may also be used by future employers or healthcare professionals to check a patient’s Q fever immune status.4